Today: 8 July 2026
Dow slips in New York after jobs data boosts rate-hike talk
17 June 2026
2 mins read

Dow sinks 506 points after Fed decision leaves rates steady, risk of hike rises

New York, June 17, 2026, 16:05 (EDT)

  • Dow Jones slipped 506.51 points, down 0.97%, ending at 51,493.16. The S&P 500 dropped 1.21%. Nasdaq Composite was off 1.35%.
  • The Federal Reserve held its benchmark rate at 3.50%-3.75%. Fresh projections now put the median federal funds rate at 3.8% for 2026, up from 3.4% in March.
  • Retail sales for May climbed 0.9%, pointing to solid consumer demand. Still, policy-sensitive stocks stayed under pressure as inflation and energy concerns linger.

Dow slips as Fed holds rates steady, signals possible hike this year. Index dropped Wednesday after a brief climb above 52,000 faded when the Federal Reserve kept rates unchanged and flagged a chance of higher borrowing costs ahead.

The blue-chip index lost 506.51 points to finish at 51,493.16. The S&P 500 dropped to 7,420.72, while the Nasdaq Composite closed at 26,021.66.

Dow futures hit a session high at 52,281.19 after closing at 51,999.67 Tuesday, but turned lower late in the day. The market drop suggests investors are still wary of the Fed’s stance on risk assets, despite continued strength in consumer spending.

Fed leaves rates steady at 3-1/2% to 3-3/4%. The decision was unanimous, 12-0. The central bank said the economy is growing at a solid pace. Inflation is still above the 2% target, with supply shocks—like energy—pushing prices higher.

The focus was on the Fed’s projections. The latest “dot plot” has the median forecast for the federal funds rate at 3.8% in 2026, compared with 3.4% back in March. Forecasts for inflation moved higher too, while the projection for 2026 growth dropped from the March numbers. Federal Reserve

Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder in New York, told Reuters, “Markets love information. It’s not a big selloff here.” Ghriskey said the move was about worries that the Fed might offer less guidance in the future. Reuters

Some strategists see the Fed as taking a hawkish turn, sticking with tight policy to deal with inflation. Kay Haigh, global head of fixed income and liquidity solutions at Goldman Sachs Asset Management, called the Fed’s path “narrow.” Ryan Detrick at Carson Group said the issue is whether the Fed goes for a hike or leaves rates where they are. Reuters

Fed officials didn’t get a break from Thursday’s economic numbers. May retail and food services sales were up 0.9% at $763.7 billion, according to the Census Bureau, before adjusting for inflation. That’s a 6.9% increase over last year. Stronger spending may help company profits, but it also adds pressure on inflation.

Salesforce slid 4.12% on the Dow, with Microsoft down 3.80%, Amazon off 3.48%, and IBM dropping 3.14%, Investing.com data showed. Those falls weighed on the Dow. The S&P 500 and Nasdaq lagged deeper as investors sold off growth and tech names.

Energy prices could swing things either way. If oil jumps or inflation proves stubborn, traders in rate futures might see better odds for a hike, which could weigh on stocks that rely on low rates. Softer inflation and steady oil would give the Fed space to hold off. Trading volume may shrink as the Juneteenth holiday nears; NYSE markets close Friday, June 19.

Roman Perkowski is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Cracow University of Economics, he previously worked in investment research and corporate finance. His coverage helps readers understand the key forces driving global financial markets and emerging industries.

Stock Market Today

  • Embassy Developments jumps 4% on Q1 pre-sales spike; Orchid Pharma gains 9% on Russia tie-up
    July 8, 2026, 12:26 AM EDT. Embassy Developments rose 4% as the company reported a 338% jump in pre-sales to Rs 868 crore for Q1 and saw collections up 54% year-on-year. Orchid Pharma was up 9% after it signed a licensing and supply deal with Pharmasyntez JSC for Exblifep, its antibiotic for complicated urinary tract infections and pneumonia in Russia. Shares of Ganesh Infraworld added 2% after a Rs 100 crore EPC contract, while Silver Touch Technologies gained 3% on a new AI platform project. EMS climbed 4% after it bagged a Rs 158.28 crore sewerage order. Traders are watching these corporate updates and fresh order wins as market volatility continues.
Nebius stock surges after Eigen AI win, eyes on Nasdaq-100 cloud move
Previous Story

Nebius stock surges after Eigen AI win, eyes on Nasdaq-100 cloud move

Coherent shares drop after $50 million CHIPS grant raises questions for AI optics
Next Story

Coherent shares drop after $50 million CHIPS grant raises questions for AI optics

Go toTop